Clinical Trial Update: Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tamoxifen with ovarian ablation and/or chemotherapy in women with Stage I–IIIA breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED